148 filings
Page 2 of 8
8-K
2df6t t8ewe0
27 Mar 24
Regulation FD Disclosure
4:01pm
8-K
mzff6i3
22 Mar 24
TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:25pm
424B5
ckaog9irujn
22 Mar 24
Prospectus supplement for primary offering
8:00am
8-K
bber91l9oalu
19 Dec 23
TFF Pharmaceuticals Announces Reverse Stock Split
6:07am
8-K
megcebz
15 Dec 23
TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors
4:06pm
EFFECT
gf0hj7nv2ljf ll4i70
13 Dec 23
Notice of effectiveness
12:15am
8-K
1stl2o
8 Dec 23
Departure of Directors or Certain Officers
4:10pm
CORRESP
6eq9ltgj
8 Dec 23
Correspondence with SEC
12:00am
8-K
b2mvml970m6 i7e5i5
4 Dec 23
TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors
5:26pm
UPLOAD
dnlkgrbpz0ff1oh9vr8l
28 Nov 23
Letter from SEC
12:00am
8-K
4hzjruuom6
22 Nov 23
Amendments to Articles of Incorporation or Bylaws
5:14pm
8-K
dsidxpeie2gfi
14 Nov 23
TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results
4:06pm
ARS
gn6dexg
4 Oct 23
Annual report to shareholders
4:10pm
DEFA14A
epecjm21kh5
4 Oct 23
Additional proxy soliciting materials
4:07pm